Department of Pathophysiology and Endocrinology, School of Medicine with the Division of Densitry in Zabrze, Medical University of Silesia, plac Traugutta 2, 41-800 Zabrze, Poland.
Endokrynol Pol. 2018;69(2):120-127. doi: 10.5603/EP.a2018.0006. Epub 2018 Feb 21.
Obesity and prostate cancer are related, but the causal relationship remains unknown. The aim of the study was to compare concentrations of leptin, adiponectin and chemerin in patients with prostate cancer and benign prostate hyperplasia and to examine associations of the adipokines with the grade of prostate cancer, interleukin-6 (IL-6), insulin resistance and anthropometric and metabolic variables.
The study group consisted of 140 men divided into two groups: I- prostate cancer (n=74) and II- with benign hyperplasia (n=66). Serum leptin, adiponectin, chemerin, IL-6 and metabolic profile were measured. Considering histological differentiation prostate cancer patients were divided into 3 subgroups: well differentiated (Gleason score ≤ 6), moderately differentiated subgroup (Gleason 7), and poorly differentiated (Gleason ≥8).
There were no differences between groups in BMI, waist circumference, HOMA-I, serum levels of total cholesterol, glucose, triglycerides, adiponectin, leptin and chemerin. However, the concentrations of PSA, leptin-to-adiponectin ratio and IL-6 were significantly higher in cancer group compared with benign hyperplasia group. In the poorly differentiated cancer subgroup, subjects had higher PSA, leptin, chemerin, IL-6 and triglycerides concentrations. Overweight and obese men with prostate cancer were more likely to have moderately or poorly differentiated cancer than those with normal BMI. In the all men serum adiponectin was significantly correlated with HOMA-I, BMI, glucose, triglycerides, cHDL. There were significant correlations between leptin and BMI, HOMA-I, waist, glucose, triglycerides and cHDL. Among all the participants we observed associations between chemerin and waist as well as triglycerides. In prostate cancer patients chemerin correlated with IL-6 and leptin. We measured significant positive correlations between Gleason score and chemerin and leptin concentrations. There was a positive correlation between adiponectin and PSA levels in all men, as well as in cancer group.
Leptin-to-adiponectin ratio and IL-6 were elevated in men with prostate cancer. Leptin, chemerin and IL-6 were associated with Gleason score. The relationships between leptin, chemerin and IL-6 were dependent on each other. Overweight and obese men had a higher Gleason score.
肥胖与前列腺癌有关,但因果关系尚不清楚。本研究的目的是比较前列腺癌和良性前列腺增生患者瘦素、脂联素和趋化素的浓度,并探讨这些脂肪因子与前列腺癌的分级、白细胞介素-6(IL-6)、胰岛素抵抗以及人体测量和代谢变量的关系。
研究组包括 140 名男性,分为两组:I-前列腺癌(n=74)和 II-良性增生(n=66)。测量血清瘦素、脂联素、趋化素、IL-6 和代谢谱。根据组织学分化,前列腺癌患者分为 3 个亚组:高分化(Gleason 评分≤6)、中分化亚组(Gleason 7)和低分化(Gleason≥8)。
两组之间的 BMI、腰围、HOMA-I、总胆固醇、血糖、甘油三酯、脂联素、瘦素和趋化素水平无差异。然而,与良性增生组相比,癌症组的 PSA、瘦素与脂联素比值和 IL-6 浓度明显更高。在低分化癌亚组中,患者的 PSA、瘦素、趋化素、IL-6 和甘油三酯浓度更高。超重和肥胖的前列腺癌患者更有可能患有中或低分化癌,而非正常 BMI 的患者。在所有男性中,血清脂联素与 HOMA-I、BMI、血糖、甘油三酯、cHDL 呈显著正相关。瘦素与 BMI、HOMA-I、腰围、血糖、甘油三酯和 cHDL 呈显著正相关。在所有参与者中,我们观察到趋化素与腰围以及甘油三酯之间存在关联。在前列腺癌患者中,趋化素与 IL-6 和瘦素相关。我们测量了在所有男性以及癌症组中,Gleason 评分与趋化素和瘦素浓度之间存在显著正相关。在所有男性中,脂联素与 PSA 水平呈正相关,在癌症组中也呈正相关。
前列腺癌患者的瘦素与脂联素比值和 IL-6 升高。瘦素、趋化素和 IL-6 与 Gleason 评分相关。瘦素、趋化素和 IL-6 之间的关系相互依赖。超重和肥胖的男性有更高的 Gleason 评分。